Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Read more
Vitafoods India 2025 – Redefining and connecting the nutraceutical ecosystem to drive growth and sustainability in the industry Read more
FDA accepts Eisai’s BLA for LEQEMBI subcutaneous autoinjector for alzheimer’s disease treatment Read more
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval pathways Read more